Examiner: MCMILLIAN, KARA RENITA

Tech Center 1600 • Art Units: 1617 1622 1623 1627

This examiner grants 30% of resolved cases

Performance Statistics

30.4%

Allow Rate

-29.6% vs TC avg

1,039

Total Applications

+37.9%

Interview Lift

1339

Avg Prosecution Days

Based on 965 resolved cases, 2023–2026

2.2%

§101 Eligibility

10.2%

§102 Novelty

47.7%

§103 Obviousness

17.7%

§112 Clarity

App #	Title	Status	Assignee
18568523	CLASS OF IMIDAZOLIDINOPYRIMIDONE COMPOUNDS AND USE THEREOF IN TREATMENT OF HSCLPP-MEDIATED DISEASES	Non-Final OA	SICHUAN UNIVERSITY

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.